Anti-Retroviral Treatment and Access to Services (ARTAS) is an intervention designed to link individuals who have been recently diagnosed with HIV to medical care. ARTAS is based on a case management model that encourages a client to establish an effective working relationship with a Linkage Coordinator.
Anti-Retroviral Treatment and Access to Services (ARTAS) is an individual-level, multi-session, time-limited intervention designed to link individuals who have been recently diagnosed with HIV to medical care. ARTAS is based on the Strengths-based Case Management (SBCM) model, which encourages the client to identify and use personal strengths; create goals for himself/herself; and establish an effective, working relationship with the Linkage Coordinator (LC).
ARTAS consists of up to five client sessions conducted over a 90-day period or until the client links to medical care – whichever comes first. ARTAS views the community as a resource for the client and client sessions are encouraged to take place outside the office or wherever the client feels most comfortable.
Following the final client session, the client may be linked to a long-term/Ryan White case manager and/or another service delivery system to address his/her longer-term barriers to remaining in care, such as substance use treatment or mental health services.
- ARTAS helps clients overcome barriers to being successfully linked to medical care.
- ARTAS aims to create a trusting, effective relationship between client and LC.
- ARTAS helps to facilitate a client’s ability to create an action plan for being linked to medical care.
Intervention Core Elements
- Build an effective working relationship between the client and LC.
- Focus on a client’s strengths:
- Conduct a strengths-based assessment.
- Encourage each client to identify and use strengths, abilities, and skills to link to medical care and accomplish other goals.
- Facilitate a client’s ability to:
- identify and pursue their own goals; and
- develop a step-by-step plan to accomplish those goals.
- Maintain a client-driven approach by:
- conducting one to five structured sessions with each client;
- conducting active, community-based case management;
- coordinating and linking each client to available community resources; and
- advocating on a client’s behalf.
Intervention Key Characteristics
- Build and maintain effective relationships with community partners and, whenever possible, sign a Memorandum of Agreement (MOA) between the implementing agency and community partners to facilitate the referral process.
- Conduct a client session with two LCs if the LC is uncomfortable with the client-selected location. The client should agree to this arrangement in advance.
- Implement a strengths-based approach to supervision.
- Provide transportation to and from the client sessions and/or medical appointments.
- Provide incentives such as gift cards or food vouchers during the five client sessions and/or for completing evaluation forms.
- Attend medical and other appointments with the client if requested.
Intervention Target Population
Any individual who is recently diagnosed with HIV, typically defined as within six to 12 months, and willing to participate in the intervention.
This training has 3 components:
- 1-hour eLearning pre-course module
- 1-hour Strengths-based Case Management eLearning module
- 2-day in-person classroom training
This training is intended for persons who will conduct ARTAS sessions with clients (LCs). Ideally, LCs should have experience providing case management or social services and can include experienced case managers, social workers, and/or HIV test counselors.
ARTAS classroom trainings are typically conducted over a two-day period. Participants must first complete the ARTAS Pre-Course Online Module and ARTAS Strengths-Based Case Management Distance Learning Course located in CDC TRAINexternal icon before they can attend the ARTAS classroom training.
To view and register for scheduled classroom trainings:
- Access the National HIV Classroom Learning Center training calendarexternal icon hosted on Cicatelli Associates, Inc.’s (CAI’s) website.
- Pre-register for your selected course via the link provided in the training calendar.
- Complete your registration on CDC TRAINexternal icon as directed when you receive an email from the National HIV Classroom Learning Center. You must join the HIV CBA Learning Group and locate the HIV CBA Training Plan in order to complete your CDC TRAIN registration for a specific classroom session (step-by-step instructionspdf iconexternal icon are available).
To access eLearning modules, including classroom training prerequisite courses:
- Log-in to CDC TRAINexternal icon and access the HIV CBA Training Plan (step-by-step instructionspdf iconexternal icon are available).
- Select the module you wish to take.
- Launch the module or save the module for later.
To request that a classroom training be scheduled:
- CDC’s directly funded health department and CBO partners may request delivery of a CDC-supported training by submitting a request in the CBA Tracking System.
- Organizations not directly funded by CDC may contact their local health department for assistance in submitting a training request.
Implementation and Marketing Materials
The materials and resources listed below support the implementation and/or marketing of ARTAS by health departments, community-based organizations, and health care or other organizations. The resources are evidence-based and designed for cost-effective, scalable implementation.
- Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, del Rio C, Strathdee S, Sansom SL, Siegal HA, Greenberg AE, Holmberg SD; Antiretroviral Treatment and Access Study Study Group. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS 2005;19(4):423-431.
- Craw JA, Gardner LI, Marks G, Rapp RC, Bosshart J, Duffus WA, Rossman A, Coughlin SL, Gruber D, Safford LA, Overton J, Schmitt K. Brief strengths-based case management promotes entry into HIV medical care: Results of the antiretroviral treatment access study-II. J Acquir Immune Defic Syndr 2008;47(5):597-606.